

Some advocate a trial of lipid emulsion** therapy (not FDA-approved for indication) when insulin and other therapies seem to be failing.Some have also suggested a role for glucagon, but its benefit beyond that of standard inotropes and vasopressors is unclear. Standard goal-directed pharmacological inotropes and vasopressors, such as epinephrine, may be used if insulin therapy is insufficient.Cardiac contractility assessed by ultrasonography.


